Philip Bonomi

Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument

David Cella, Amy E. Bonomi, Stephen Lloyd et al. · Lung Cancer · 1995 · 750 citations

Social Sciences, Oncology, Functional Assessment +10

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

Leena Gandhi, D. Ross Camidge, Moacyr Oliveira et al. · Journal of Clinical Oncology · 2011 · 591 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase II Trial of Cetuximab in Patients With Previously Treated Non–Small-Cell Lung Cancer

Nasser H. Hanna, Rogério Lilenbaum, Rafat Ansari et al. · Journal of Clinical Oncology · 2006 · 185 citations

Medicine, Oncology, Pharmacology +16

Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Suzanne E. Dahlberg, Joan H. Schiller, Philip Bonomi et al. · Journal of Thoracic Oncology · 2013 · 110 citations

Medicine, Oncology, Medical Oncology +8

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

Douglas H. Johnson, Andrew T. Turrisi, A. Y. Chang et al. · Journal of Clinical Oncology · 1993 · 67 citations

Medicine, Oncology, Radiation Oncology +16